Prevalence of EBV, HHV6, HCMV, HAdV, SARS-CoV-2, and Autoantibodies to Type I Interferon in Sputum from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. — CFSMEATLAS
Prevalence of EBV, HHV6, HCMV, HAdV, SARS-CoV-2, and Autoantibodies to Type I Interferon in Sputum from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Hannestad, Ulf, Allard, Annika, Nilsson, Kent et al. · Viruses · 2025 · DOI
Quick Summary
This study tested sputum (saliva and mucus) samples from ME/CFS patients and healthy people to look for viruses and signs of immune dysfunction. Researchers found that ME/CFS patients had significantly higher levels of Epstein-Barr virus (EBV) compared to controls, but surprisingly, most people carried human herpesvirus 6 at similar levels. The study suggests that ME/CFS patients may have trouble fighting off viruses, but this isn't simply due to the immune system attacking itself.
Why It Matters
Understanding why ME/CFS patients have persistent viral reactivation and impaired antiviral immunity is crucial for developing targeted treatments. This study provides evidence that the mechanism may involve viral strategies to evade interferon response rather than simple autoimmunity, opening new research directions for intervention.
Observed Findings
ME/CFS patients had significantly higher EBV sputum shedding compared to controls (p=0.0256).
Human herpesvirus 6 (HHV6) was present in approximately 50% of all participants at similar levels regardless of group.
Human adenovirus was detected only in cases of immunosuppression or severe ME/CFS.
Autoantibodies to type I interferon were similar between ME/CFS and controls, except elevated in one severe ME/CFS case.
HCMV and SARS-CoV-2 were found only in the immunosuppressed controls.
Inferred Conclusions
ME/CFS patients have significantly elevated EBV reactivation compared to healthy controls, suggesting impaired antiviral immunity.
Type I interferon autoantibodies cannot explain IFN-I dysfunction in most ME/CFS cases, suggesting alternative mechanisms such as viral receptor degradation may be responsible.
Viral evasion strategies that interfere with interferon signaling pathways may be a key mechanism in ME/CFS immune dysfunction.
The findings are partially consistent with mechanisms observed in severe COVID-19, suggesting shared pathophysiology between ME/CFS and post-viral syndromes.
Remaining Questions
What specific viral mechanisms are used by EBV to evade or suppress type I interferon effects in ME/CFS patients?
What This Study Does Not Prove
This study does not prove that EBV reactivation causes ME/CFS, only that it is more frequently present in sputum. The cross-sectional design cannot establish causality or determine whether elevated EBV is a cause, consequence, or marker of disease. It also cannot rule out other immune dysfunction mechanisms beyond those tested.